Virus-specific cytotoxic T lymphocytes (CTL) recognize virus-derived peptides presented by major histocompatibility complex (MHC) class I molecules on virus-infected cells. Such peptides have been isolated from infected cells and were compared to synthetic peptides . We found previously the Kd-or Db-restricted natural influenza nucleoprotein peptides to coelute on reversed phase high performance liquid chromatography columns with certain peptidic by-products present in synthetic peptide preparations . Here we show by extensive biochemical and immunological comparison that the natural peptides in all respects behave as the surmised synthetic nonapeptides, and thus, must be identical to them. The absolute amounts of these natural peptides contained in infected cells could be determined to be between 220 and 540 copies by comparing with defined amounts of pure synthetic nonapeptides. The comparison of the natural Kd-restricted peptide with published synthetic peptides known to contain other Kd-restricted CTL epitopes suggested a new MHC allele-specific T cell epitope forecast method, based on the defined length of nine amino acid residues and on critical amino acid residues at the second and the last position .
Virus-specific cytotoxic T lymphocytes (CTL) recognize virus-derived peptides presented by major histocompatibility complex (MHC) class I molecules on virus-infected cells. Such peptides have been isolated from infected cells and were compared to synthetic peptides . We found previously the Kd-or Db-restricted natural influenza nucleoprotein peptides to coelute on reversed phase high performance liquid chromatography columns with certain peptidic by-products present in synthetic peptide preparations . Here we show by extensive biochemical and immunological comparison that the natural peptides in all respects behave as the surmised synthetic nonapeptides, and thus, must be identical to them. The absolute amounts of these natural peptides contained in infected cells could be determined to be between 220 and 540 copies by comparing with defined amounts of pure synthetic nonapeptides. The comparison of the natural Kd-restricted peptide with published synthetic peptides known to contain other Kd-restricted CTL epitopes suggested a new MHC allele-specific T cell epitope forecast method, based on the defined length of nine amino acid residues and on critical amino acid residues at the second and the last position .
T he function of MHC class I molecules is to present peptides derived from cellular proteins to CD8+, MHC class I-restricted T cells (1) (2) (3) (4) (5) (6) (7) . A considerable fraction of alloreactive T cells also recognizes peptides derived from cellular proteins (K. Falk, unpublished data) . Such peptides can, in principle, be derived from protein occurring in different cellular compartments (8) . It is not known, however, where and how the peptides are made from the protein, and how they come into contact with MHC class I molecules . Based on the blocking of MHC class I-restricted antigen presentation with Brefeldin A (9, 10) and other experiments (11) , it was speculated that MHC molecules bind peptides during or shortly after assuming their final structure in the endoplasmic reticulum . It is not clear, however, whether nascent MHC molecules bind preformed peptides, or rather larger molecules, or even complete protein, which then might be trimmed to those peptides found later on bound to mature MHC molecules (12) .
To better understand these processes, the exact knowledge of the identity of MHC-presented peptides should be useful. We have recently shown that cellular peptides can be isolated from complete cells, or from purified MHC molecules, and that the peptides isolated from complete cells, without prior enrichment for MHC molecules, are still heavily dependent on MHC expression in the respective cells (6, 12, 13 ; K . Falk, unpublished data) .
For the minor histocompatibility and viral antigens tested, the respective MHC-dependent peptide as seen by a given CTL always elutes a single, sharp activity peak from reversed phase HPLC columns, indicating that the cell makes exactly one well-defined peptide to be seen by a given CTL . The peptide presented by influenza-infected H-2d cells to Kdrestricted, influenza nucleoprotein-specific CTL coelutes on a reversed phase HPLC column together with a minor byproduct present in a synthetic peptide preparation made according to a peptide previously reported to contain a Kd-restricted influenza nucleoprotein epitope, TYQRTRALVRTG (6, 14) . The minor byproduct was determined by ion spray mass spectrometry to be a nonapeptide contained in the above preparation . Similar observations were made for a Db-restricted CTL epitope formerly described to be contained in a 16-amino acid residue peptide also from influenza nucleoprotein, IASNENMETMESSTLE (2, 6) .
To test whether such synthetic nonapeptides really are identical with the naturally processed peptides, we did extensive biochemical and immunological comparisons. Based on the data obtained, we quantified the number of nucleoprotein peptide copies present in influenza-infected cells. In addition, we introduce a new hypothesis on the prediction of T cell epitopes in an MHC allele-specific way, which is based on the knowledge of the identity of naturally processed viral peptides.
Materials and Methods
Virus and Cells. Influenza A/PR/8/34 virus was grown in the allantoic sacs of 11-d-old embryonated chicken eggs and stored at -70°C. Infectivity was tested by determining the titer of hemagglutinating units (HAU;m 15). EL4 (H-2b), P815 (H-2d), and PLHTR (H-2d) tumor cells were grown in RPMI 1640 supplemented with 5% FCS and antibiotics. PLHTR is a subline of P815 selected for high transfection efficiency (16) and is easier infectable with influenza virus than is P815 in our hands (H. Schild, unpublished data). This line was erroneously called P815 TR in a previous publication (6) . The CTL line HASI is specific for influenza nucleoprotein peptide TV (for abbreviations of peptides, see Tables 1 and 2 ) and is Kd restricted (6) . The line 28B90 was derived by stimulating spleen cells of a C57BL/6 mouse (preimmunized with 50 HAU of virus), with crude IASNENMET MESSTLE peptide (1 Itg/ml) in vitro. This line has essentially the same specificity as has the line LS9 (6), i.e., is specific for A-M and is Db restricted . Both CTL lines were kept by weekly restimulation with irradiated (33 Gy) syngeneic spleen cells and the respective peptide in a medium supplemented with 10% FCS and antibiotics and Con A-induced rat spleen cell supernatant as a source of IIL2 .
Vitus Infections. EL4 cells were grown in roller bottles to a density of 1-2 x 106 cells/ml . Cells were infected by incubation with 15 x 104 HAU of virus for 109 cells in PBS (without FCS) for 12 h at 37°C ; P1 .HTR cells were grown in plastic petri dishes (14.5-cm diameter) to near confluent density (-101 cells/dish). Medium was removed and replaced by PBS (without FCS) containing infectious virus (15 x 10^HAU/109 cells) . Incubation at 37°C was for 12 h. Success of infections was controlled for by testing a sample of infected cells for recognition by virus-specific CTL.
Extraction of Viral lkptides from Infected Cells. 109 virus-infected cells were pelleted and suspended with 15 ml of 0.1% (vol/vol) TFA. Cells were disrupted by douncing (10 strokes) followed by ultrasonication (20 pulses of 1 s; Sonifier BIS; Branson, Heusenstamm, Germany) . Suspensions were then stirred for 30 min at 4°C; pH was kept at 2.0 with 1% TFA. The supernatant taken after centrifugation (30 min; 180,000 g; 4°C) was lyophilized, resolved in 0.1% TFA, and subjected to a G25 Sephadex (Pharmacia Fine Chemicals, Piscataway, NJ) column (bed volume, 50 ml; sample volume, 3 ml; eluent, 0.1% TFA; flow rate, 0.5 ml/min). Material of Mr <5,000 (excluded from this column) was collected, lyophilized, and resolved in 1 ml of 0.1% TFA for HPLC separation.
Synthetic Aptides. Peptides (Tables 1 and 2 ) with 000H-terminal amino acid residue L, M, or E, respectively, were synthesized by solid phase techniques on a peptide synthesizer (model 430 A; Applied Biosystems, Foster City, CA) using our own Fmoc program and commercially available Fmoc-amino acid p-benzyloxybenzylalcohol-resins and Fmoc-protected amino acids (Novabiochem, Sandhausen, Germany) . Fmoc-amino acids were side chain protected as follows: Gln(Trt), Thr(tBu), Ser(tBu), Glu(tBu), I Abbmdations used in this paper: HAU, hemagglutinating units; VSV, vesicular stomatitis virus.
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Quantification of Viral Peptides Asn(Trt), Arg(Mtr), Tyr(tBu) . Fig. 1 , g and h. Flow rate, 1 ml/min ; fraction size, 0.5 ml . Elution was monitored by measuring ultraviolet light absorption at 220 nm in a continuous flow detector. Individual samples were dried by vacuum centrifugation and stored at -70°C, if not immediately used for CTL assays . CTL Assays. EL4 (H-2b) or P815 (H-2d) target cells were labeled with "Cr according to standard methods. Synthetic or natural peptides were titrated into 96-well round-bottomed microtiter plates (50 td/well). Target cells (10`/well in 100 pl of medium) were added, followed by incubation at 37°C for 90 min. CTL suspensions (50 pl) were added to give a CTL/target ratio of 2:1 to 10 :1. Assay plates were incubated for 6 h at 37°C . 100-P1 supematant from each well was harvested and the radioactivity detected in a gamma counter. Specific lysis was determined using the formula : 100 x (cpm released by CTL -cpm released with medium alone)/(cpm released by detergent -cpm released with medium alone) . For assays, ot medium containing 10% FCS was used. Detergent used to determine maximum release of target cells was 10% Zaponin (Coulter Instruments, Hialeah, FL). Spontaneous "Cr release of target cells was between 9 and 28%.
Results
The Naturally Processed Kd-restricted Peptide from Influenza Nucleoprotein . P1.HTR tumor cells (H-2d) were infected with A/PR/8/34 influenza virus. Peptides were extracted by acid elution, separated by reversed phase HPLC (TFA/ acetonitrile), and tested for recognition by Kd-restricted, influenza nucleoprotein-specific HASI CTL as described (6; Fig . 1 a) . We found that the natural peptide coeluted with a synthetic byproduct of M, 1,107 contained in a preparation of TYQRTRALVRTG (abbreviation, T-G; Mr 1, 421 ; 14) . Therefore, peptides according to TYQRTRALV (TV, M 1,107) and several other peptides contained in or overlapping with TG with M "1,000 (see Table 1 ) were synthesized, and chromatographed under the same conditions as the natural peptide . The elution behavior of these peptides is indicated in Fig. 1 a by marks. Three of the synthetic peptides eluting at similar positions as the natural peptide were chromatographed under different conditions (phosphate buffer/acetonitril ; Fig . 1 c) and compared to the elution behavior of the natural peptide under the same new conditions ( Fig. 1 e) . The TYQRTRALV peak coeluted exactly with the natural peptide, whereas the other two synthetic peptides eluted with considerably different retention times compared to the natural one. Both TYQRTRALV and the natural peptide were chromatographed using yet another parameter (heptafluorobutyric acid [HFB]/acetonitrile; Fig.  1 g) ; again, they both behaved identically. Thus, the naturally processed Kd-restricted peptide from influenza nucleo- Table 1 are recognized with much inferior efficiency. The Natural Db-restricted Peptide from Influenza Nucleoprotein . Acid extracts from influenza-infected EL4 tumor cells (H-2b) were separated and analyzed as for the H-2d tumor cells, except that Db-restricted CTL 28B90 were used for detection (Fig. 1 b) . The elution behavior of synthetic peptide ASNENMETM, which had been suspected to be the one coeluting with the natural Db-restricted peptide (6), as well as some other peptides of similar molecular mass (Table 2) , contained in the IASNENMETMESSTLE (2) sequence is indicated in Fig. 1 b by marks . Three peptides eluting similarly as the natural peptide, peptides A-M, S-M, and A-E, as well as the natural peptide, were chromatographed using a phosphate buffer/acetonitrile gradient ( Fig. 1, d and f) . Only ASNENMETM coeluted with the natural peptide ; note the shoulder in the activity peak of the natural peptide, which parallels the shoulder in the activity peak of AM (Fig. 1f) . Coelution of both peptides was also observed with the HFB/ acetonitrile gradient (Fig. 1 h) . Thus, the natural Db-restricted influenza nucleoprotein peptide must be ASNENMETM. In line with this is the highly efficient recognition (<1 pg/ml [1 pM]) of AM by Db-restricted CTL as compared to the other peptides (Table 2) . Thus, both Kd-and Db-restricted NP, nucleoprotein . " Single letter amino acid code . t P815 cells (H-2d) were incubated with titrated concentrations of the respective peptides (crude) and assayed for killing with HASI CTL. The numbers indicate specific lysis at 1 kg/100 ng/10 ng/1 ng/100 pg/10 pg/1 pg/100 fg peptide per well (150 ul) . Figure 1 . Identification of naturally processed viral peptides by biochemical comparison to synthetic peptides . Naturally processed influenza virus peptides were extracted from infected P1.HTR cells and HPLC separated as described (6) . The fraction recognized by the influenza nucleoprotein-specific, Ka-restricted CTL line HAS[ was further separated using different HPLC parameters (left panels) . Similarly, the naturally processed influenza peptide recognized by Db-restricted CTL 28B90 was extracted from EL4 cells, separated by HPLC, and subjected to further HPLC separation (right panels) . Recognition of individual fractions by CTL was monitored by incubating the respective fractions with P815 target cells and measuring their lysis using HASI CTL (squares and circles), or by incubating fractions with EL4 target cells and measuring their lysis with 28B90 CTL (upright and im~erted triangles) .
( " .""/ ; " "" . " ) Fractions from control gradients performed without samples. This is an important control, since minor peptide contaminations left over from previous runs might interfere with the extremely sensitive CTL assay. These control gradients were always run before peptide separations . 14, .~' .. ". . (e-h) Aliquots of 109 EL4 cells were left uninfected (e and J), were mixed with 10 ng A-M synthetic peptide 0, or were infected with influenza virus (g and h) . Each aliquot was subjected to acid extraction . The resulting material was separated by reversed phase HPLC and monitored by measuring ultraviolet light absorption at 220 nm ( ). Individual fractions were tested for recognition by HASI CTL (Kd-restricted) on P815 target cells (") or by 281390 CTL (Db-restricted) on EL4 target cells (A), or were incubated with P815 (O) or EL4 (A) target cells without CTL to control for fraction toxicity. (Fig . 2) . Fractions containing active peptides were retested in titrated concentrations (Fig. 3) . By comparison of the titration curves, it was determined that the recovery of admixed synthetic TV from P1 .HTR cells was approximately quantitative (Fig . 3, b and c) , and that from the first batch of infected H-2d cells 1 ng of natural TV was eluted (Fig. 3 d) . From the second batch, 0.4 ng of natural TV was eluted (Fig . 3 e) The recovery of admixed synthetic AM from EL4 cells was 25% (Fig. 3, g and h) ; assuming the same recovery rate, both batches of infected EL4 cells contained 0.4 ng of natural A-M, or 220 AM molecules per cell .
Comparison of Natural Peptides to Other Peptides Known to
Contain CTL Epitopes. Table 3 dent : apart from the uniform Tyr at position 2, the last position is always occupied by an amino acid residue with a side chain methyl group (Val, Ile, Thr, Ala, or Leu) . The third position is frequently Glu, Leu, or Val; in the fifth position Val, Asn, and Ser ; and in the sixth Glu and Ala are found repeatedly. On the other hand, the fourth position is in all cases occupied by a different amino acid, with the exception of the homologous peptides. Similarly, positions 1, 7, and 8 are highly variable. A comparison of the natural Db-restricted influenza nucleoprotein peptide with other peptides known to contain Db-restricted epitopes was not informative, because the available database is smaller, and since a sentinel residue such as Tyr for Kd-restricted peptides was not evident . It is clear, however, that the Db-restricted peptide does not fit into the pattern observed for Kd-restricted peptides ; neither does the naturally Kb-restricted peptide of vesicular stomatitis virus (7) .
Discussion
The naturally processed influenza nucleoprotein peptide presented by Kd molecules to CTL was determined to be the nonapeptide TYQRTRALV . The corresponding Dbrestricted peptide is ASNENMETM . Knowing exactly the peptides presented by virus-infected cells, it was possible to quantitate the number of peptide copies present in a virusinfected cell by comparing in a CTL assay the titration curves of eluted natural peptides with those of defined concentrations of the corresponding synthetic peptides. From infected P1 .HTR tumor cells (H-2d), between 220 and 540 copies of TYQRTRALV were extracted, and from infected EL4 tumor cells (H-2b), 220 copies of ASNENMETM .
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An unknown parameter may have biased these figures, namely the efficiency of peptide extraction from cells. The efficiency of peptide recovery during HPLC has been controlled for. Most of the naturally processed peptides are likely to be eluted from MHC molecules located in the cytoplasm or on the plasma membrane. Although the condition used for extraction (0.1% TFA) may suggest quantitative dissociation of MHC molecules and peptides, we cannot measure this parameter. On the other hand, we do not know how many of the peptide copies isolated come from the cytoplasm and how many from the plasma membrane . There is no easy way to allocate the origin of eluted peptide to either of the two compartments. Under the assumption that half of the peptides eluted from whole cells come from MHC molecules inserted into the plasma membrane, the number of peptides presented on the cell surface would be -100 for infected EL4 cells, and -100-300 for infected P1 .HTR cells. These numbers are consistent with the minimal number of peptide/ MHC complexes for stimulating MHC class II-restricted T cells (17, 18) . If the tumor cells used in our study express 300,000 Kd or Db molecules per cell, respectively, these should be able to present 1,000-3,000 different peptides simultaneously in sufficient densities to allow T cell recognition . In normal cells, all of these are self peptides ; indeed, normal cells can be recognized by quite a lot of different peptidespecific CTL (12, 13 ; K . Falk, unpublished data) . The body cells of individual human beings typically express four different MHC class I molecules capable ofpresenting peptides (HLAA and -B in two allelic forms each) ; normal outbred mice have four or six such molecules. This implicates that one cell (with high MHC expression) is able to present 12,000 different pep- tides simultaneously. This appears a high number at first glance; the number, however, is too low to guarantee a full covering of any mutation occurring in the genes for the 10,000 proteins or so expressed in a cell, since each average sized protein could give rise to 100 or more different nonapeptides. The number of simultaneously presented peptides is probably even lower than estimated above, since the self peptide mixtures eluted from MHC class I molecules contain 7-10 dominant peptides likely to occupy much >300 MHC molecules per cell (7; O. Rotzschke, unpublished data) . Thus, if CTL are involved in the surveillance of normal cells against somatic mutation, as has been speculated, this surveillance has to be incomplete, even if our calculation should grossly underestimate the actual number of different peptides simultaneously presented by a cell . In the case of cells infected with virus or larger parasites, however, the situation is not so hopeless for a successful surveillance by CTL . Each of the parasites needs at least several of its proteins expressed intracellularly; if, on average, the cell can afford to present one peptide per protein to CTL, the chance for hitting a peptide derived from a foreign protein expressed in addition to the 10,000 or so self proteins is quite high in infected cells . It should be emphasized in this context that a cell has no possibility to distinguish between self or nonself origin of its proteins .
The data base of naturally processed peptides presented by MHC class I molecules consists of only three peptides up to now ; in addition to the Kd-and Db-restricted influenza epitopes dealt with here, a Kb-restricted vesicular stomatitis virus (VSV) epitope has been reported to be an octapeptide (7) . This limited information does not allow yet to generalize that MHC class I-restricted T cell epitopes are always nona-or octapeptides, although this is not unlikely. Before a larger data base on naturally processed epitopes is available, however, the comparison of natural peptides to other peptides known to contain CTL epitopes can be informative, as discussed below.
It has been observed that a Tyr residue is common to peptides containing Kd-restricted epitopes. One could speculate then that Tyr residues in Kd-restricted epitopes might always be at position two, as is the case with the natural Kdrestricted epitope TYQRTRALV. Under this assumption, comparison of the latter epitope with other peptides containing Kd-restricted epitopes suggests a consensus sequence for Kd-restricted T cell epitopes (Table 3) . Peptides presented by Kd molecules generally might be nonapeptides, might have a Tyr residue at position 2, and an amino acid residue containing a side chain methyl group (Val, Ile, Thr, Ala, or Leu) at position 9 ( Table 4 ). The other residues appear to be more variable, although there seem to be preferential occupancies at positions 3, 5, or 6 . This hypothetical consensus motif is consistent with replacement studies carried out by Maryanski et al . (19) , who showed that in derivatives of the Kd-restricted peptide RYLENGKETLQRA, all amino acids 43 2 Quantification of Viral Peptides
Indicates variable occupancy . Size of letters corresponds to the importance of the respective residue .
between Tyr and Thr can be replaced by Pro residues without abrogation of binding capacity to Kd. In addition, replacement of Tyr at both the above-mentioned peptide and the peptide TYQRTRALVTG for Ala severely reduced binding capacity to Kd. The consensus motif hypothesized here has now essentially been confirmed by sequencing the mixture of self peptides eluted from Kd molecules (20) . It should be emphasized here, however, that binding to MHC is only one requirement a peptide has to fulfill to be naturally presented by MHC ; other constraints may include intracellular transport mechanisms (11) of proteins/peptides, and the intracellular proteolysis of protein yielding the final peptide. The comparison in Table 3 leading to the consensus motifin Table  4 is based only on epitopes actually presented by infected or transfected cells ; peptides shown to just bind to Kd were not considered in both tables.
The natural Db-restricted influenza peptide ASNEN-METM does not fit into the Kd-restricted consensus sequence; neither does the natural Kb-restricted VSV sequence RGYVYQGL . Thus, it may emerge that each MHC allelic product has its own peptide motif that it likes to present to T cells . This notion has been confirmed by recent work from this laboratory (20) . Similar speculations have been formulated earlier (19) (20) (21) (22) ; the notion, however, is significantly strengthened by the identification of naturally presented peptides. It may be useful, therefore, to refine any T cell epitope forecasts to allele-specific ones, like the one offered in Table  4 for Kd-restricted epitopes .
The presentation of nonrandom, relatively rare allele-specific peptide motifs by MHC molecules could be a way for cells to ensure that not too many peptides from a single abundant protein are presented on the expense of peptides from less abundant proteins . The relatively rare occurrence of allelespecific peptide motifs (for example, a Tyr residue followed by either of Val, Ile, Thr, Ala, or Leu exactly seven positions later for a Kd-restricted peptide ; the chance for this is 1 in 80 random nonapeptides) also implies that it is of advantage for an individual to express several different MHC molecules to increase the chance that one of the peptide motifs covered is contained in a given foreign protein, that is, to be heterozygous for MHC alleles . 
